HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer

Clinical trial NCT07232875 · RECRUITING

Trial details

NCT number: NCT07232875
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting

Start date: 2025-11-21
Primary completion: 2029-04-01
Enrollment: 588

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.